NLRP3 promoter methylation
1 paper studies it2 findings
- Humans1
Upstream
1Age
upin humans1
1 study
Age
upin humans1
age increases NLRP3 promoter methylation in humans (p = 0.0038 and p = 0.0018).
“In IBD adults, methylation levels at both NLRP3 CpG sites increased with patients' age (p = 0.0038 and p = 0.0018, respectively).”
Humansinflammatory bowel diseasen = 47
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Associations
1Poor glucocorticoid response
downin humans1
1 study
Poor glucocorticoid response
downin humans1
NLRP3 promoter methylation is associated with poor glucocorticoid response in humans (p = 0.045 and p = 0.038).
“poor glucocorticoid response after one month of therapy in pediatric patients was associated with lower methylation levels at both CpG sites (p = 0.045 and p = 0.038, respectively)”
Humansinflammatory bowel disease1 monthn = 94
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Latest
Biomedicine & Pharmacotherapy
NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel disease
Cohort study in peopleInflammatory bowel disease